ADHUMA Trademark

Trademark Overview

On Tuesday, March 9, 2021, a trademark application was filed for ADHUMA with the United States Patent and Trademark Office. The USPTO has given the ADHUMA trademark a serial number of 90567845. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, August 27, 2024. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The ADHUMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology
adhuma

General Information

Serial Number90567845
Word MarkADHUMA
Filing DateTuesday, March 9, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Friday, August 13, 2021ASSIGNED TO EXAMINER
Friday, August 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 12, 2021NEW APPLICATION ENTERED
Tuesday, June 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 10, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 22, 2022PETITION TO REVIVE-GRANTED
Wednesday, June 22, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, May 16, 2022NOTICE OF ALLOWANCE CANCELLED
Monday, June 20, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, June 22, 2022NOTICE OF REVIVAL - E-MAILED
Friday, July 29, 2022NEW NOA TO ISSUE
Wednesday, February 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 22, 2023SOU EXTENSION 1 FILED
Wednesday, February 22, 2023SOU EXTENSION 1 GRANTED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, July 29, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 1, 2023SOU EXTENSION 2 FILED
Friday, September 1, 2023SOU EXTENSION 2 GRANTED
Tuesday, September 5, 2023EARLY EXTENSION OF USE REFUSED
Friday, March 1, 2024SOU EXTENSION 3 FILED
Friday, March 1, 2024SOU EXTENSION 3 GRANTED
Friday, March 1, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 27, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 27, 2024SOU EXTENSION 4 FILED

Related Keywords

adhuma preparations pharmaceutical respiratory pain neurological urogenital menopausal urological hematology disorders